X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Protect your health: Important disaster preparedness tips for Harvey and Irma

By Guest Contributor  |    September 6, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Fighting disease Together: New ads feature patients and the researchers behind today’s breakthroughs

By Robert Zirkelbach  |    April 19, 2017
Today, we launched our next wave of advertising as part of the GOBOLDLY™ campaign, titled Together, featuring the stories of researchers developing cutting-edge breakthroughs alongside patients...   Read More

10 years of living and managing type 1 diabetes; lessons learned

By Guest Contributor  |    November 30, 2016
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Medicare Monday: Progress in fight against diabetes is one more thing to be thankful for this year

By Nicole Longo  |    November 21, 2016
30 million. 1.4 million. 11 million. 86 million. These numbers on their own may mean nothing, but in the context of diabetes, they paint an entirely different picture. More than 30 million...   Read More

Reflecting on terrific progress in treating diabetes

By Bill Chin, M.D.  |    November 17, 2016
There is no doubt that diabetes is a complex disease to diagnose and treat. That’s something I’ve seen firsthand as an endocrinologist. Over the years, I treated a number of patients that had a...   Read More

New PhRMA report: More than 170 medicines in development for diabetes offer patients longer, healthier lives

By Hannah Mooney  |    November 14, 2016
Today, there are more than 30 million Americans suffering from type 1 or type 2 diabetes. Roughly 5 percent of patients have type 1 and 90 to 95 percent suffer from type 2, highlighting the...   Read More

Burden on patients: Insurance benefit design’s impact on patient access to medicines

By Allyson Funk  |    June 30, 2016
Last week, we looked at access to medicines in health insurance exchanges for HIV/AIDS, oncology, cystic fibrosis, mental health and multiple sclerosis. The analysis by Avalere Health presents...   Read More

New report celebrates a decade of progress in chronic diseases

By Holly Campbell  |    February 25, 2016
In the last 10 years, incredible progress has been made by the biopharmaceutical industry in the treatment of chronic diseases. With about half of all Americans, or 117 million people, living with...   Read More

Patients and researchers say “we’re fighting back” in new “From Hope to Cures” ads

By Ieva M. Augstums  |    February 8, 2016
Diagnosed with type 1 diabetes at a young age, five-year-old Rhys has not let his diagnosis be his destiny. He enjoys life to the fullest, from playing sports to having treats at a friend’s...   Read More

Ask About Adherence: Q&A with Dr. Helaine Resnick on diabetes care

By Samantha Dougherty  |    December 17, 2015
Ask About Adherence is a blog series featuring Q&A’s with experts in medication adherence. In this post, we speak with Helaine E. Resnick, PhD, MPH about her recently published literature review...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates